GovGazette
Menu

Historical award

Inhalon Biopharma, Inc.

This record is historical buying context, not open work.

How current is this award history?

Fiscal year 2025: data through (14 days old).

Fiscal year 2026: data through (14 days old).

Official release availability details

Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Current award value
$2,234,650.00
Potential award value
$2,234,650.00
Total obligated to date
$2,234,650.00

Recorded work

DEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL ATTACHMENT AND ENTRY REVISED STATEMENT OF WORK AND PRINCIPAL INVESTIGATOR CHANGE.

Award activity

Obligations in covered fiscal years
$0.00
Transactions in covered fiscal years
2

Award value and obligated funds describe different amounts. Review the official record for the full transaction history.

Record identifierCONT_AWD_HT942524C0076_9700_-NONE-_-NONE-